BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 21, 2008
View Archived Issues
Promising phase II results of idebenone in Duchenne muscular dystrophy
Read More
In vivo antitumor efficacy seen with Trop-2 antibody AR47A6.4.2
Read More
Preclinical studies test IMGN-901 against ovarian cancer, multiple myeloma
Read More
OPL-CCL2-LPM active in mouse model of MS
Read More
Novel analgesic agents disclosed in recent patent literature
Read More
FDA approves Alcon's Patanase nasal spray for seasonal allergic rhinitis
Read More
Santarus is to terminate U.S. copromotion agreement with Otsuka for Zegerid
Read More
MedImmune initiates phase I and phase II clinical trials of anti-IL-13 antibody CAT-354
Read More
DSMB recommends continuation of Anthera's phase II IMPACTS clinical trial of A-001
Read More
Paratek completes USD 40 million private placement to finance phase III studies of PTK-0796
Read More
Zelos and Aegis enter collaboration for intranasal delivery of ZT-031 for osteoporosis
Read More
Lev Pharmaceuticals submits complete response to FDA for Cinryze for hereditary angioedema
Read More
New PPAR agonists evaluated for lipid effects in mice
Read More
Modern Biosciences initiates phase I rimcazole trial in cancer
Read More
Recent patents report new treatment options for inflammatory and autoimmune diseases
Read More
Shionogi receives marketing and manufacturing approval for Irbetan
Read More
Boston Scientific acquires CryoCor for approximately USD 17.6
Read More
Insmed receives U.K. approval to initiate phase I study of follow-on biologic of Neupogen
Read More
Pfizer and Avant enter into licensing agreement for EGFRvIII vaccine CDX-110
Read More
Sepracor launches Omnaris nasal spray for allergic rhinitis in the U.S.
Read More
Arpida reports positive results from two pivotal phase III trials with iclaprim in cSSSI
Read More
GSK and Regulus enter strategic alliance to develop microRNA-targeted therapeutics
Read More
Orion seeks expanded indication for Stalevo in Parkinson's disease in U.S. and Europe
Read More
Renovo reports positive results from two phase II clinical trials of Juvista for scars
Read More
